Factors Associated with In-stent Restenosis in Patients Following Percutaneous Coronary Intervention

Factors Associated with In-stent Restenosis in Patients Following Percutaneous Coronary Intervention

Show other versions (1)

Aim: to determine factors associated with In-Stent Restenosis (ISR) in patients following Percutaneous Coronary Intervention (PCI). Methods: a retrospective cross-sectional study was conducted using secondary information from medical records of post-PCI patients who underwent follow-up of angiograp...

Full description

Saved in:

Bibliographic Details
Main Authors:	Dedi Wihanda, Idrus Alwi, Hamzah Shatri, E. Mudjaddid E. Mudjaddid
Format:	Article
Language:	English
Published:	Interna Publishing 2015-07-01
Series:	Acta Medica Indonesiana
Online Access:	https://mail.actamedindones.org/index.php/ijim/article/view/34
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Factors Associated with In-stent Restenosis in Patients Following Percutaneous Coronary Intervention
by: Dedi Wihanda, et al.
Published: (2015-07-01)

Increased Heart Rate Variability following Elective Percutaneous Coronary Intervention in Patients with Stable Coronary Artery Disease and Preprocedural Anxiety
by: Tessa Oktaramdani, et al.
Published: (2019-01-01)

Prognostic factors for stent restenosis in patients with coronary artery disease undergoing percutaneous coronary intervention
by: M. А. Meshkova, et al.
Published: (2025-06-01)

Intravascular ultrasound assessment of stent edge restenosis mechanisms and treatment outcomes following percutaneous coronary intervention
by: Xi Wu, et al.
Published: (2025-05-01)

Advanced chronic total occlusion–percutaneous coronary intervention techniques in managing complex in-stent restenosis
by: Gautam Swaroop
Published: (2025-05-01)

Catlet scoring system as a new predictor for in-stent restenosis in patients with chronic coronary artery disease undergoing percutaneous coronary intervention with drug-eluting stent
by: Juan Wang, et al.
Published: (2025-01-01)

Clinical Significance of Optical Coherence Tomography–Guided Percutaneous Coronary Intervention for In‐Stent Restenosis Within Drug‐Eluting Stents: Impact on Patient Outcomes
by: Yan Han, et al.
Published: (2024-11-01)

Pre‐Percutaneous Coronary Intervention C‐Reactive Protein Levels and In‐Stent Restenosis: A Systematic Review and Meta‐Analysis
by: Himanshu Rai, et al.
Published: (2025-05-01)

RESTENOSIS RISK FACTORS AFTER CORONARY ARTERY STENTING IN OBESE PATIENTS
by: N. G. Veselovskaya, et al.
Published: (2013-06-01)

Restenosis risk factors after coronary stenting in metabolic syndrome patients
by: N. M. Danilov, et al.
Published: (2007-04-01)

Recent Advances in the Treatment of Coronary In-Stent Restenosis
by: Luca Sartore, et al.
Published: (2024-12-01)

Restenosis pathophysiological mechanisms and genetic markers after percutaneous coronary interventions
by: Yu. A. Shuvalova, et al.
Published: (2007-10-01)

A positive linear correlation between the triglyceride-glucose index and in-stent restenosis after percutaneous coronary intervention in patients with coronary heart disease
by: Jin Mao, et al.
Published: (2025-07-01)

Application of Nanoliposome Alprostadil in the Perioperative Period of Percutaneous Coronary Intervention to Reduce In-Stent Restenosis: A Systematic Review and Meta-Analysis
by: Decai Zhu, et al.
Published: (2023-01-01)

RISK FACTORS OF CORONARY ARTERIES RESTENOSIS AFTER STENTING IN POSTMENOPAUSAL WOMEN WITH OBESITY
by: E. S. Osipova, et al.
Published: (2018-06-01)

PREDICTORS OF CORONARY ARTERIES RESTENOSIS AFTER STENTING IN OBESE WOMEN
by: N. G. Veselovskaya, et al.
Published: (2014-09-01)

Research advances in the etiology of in-stent restenosis of coronary arteries
by: Hangrui Bai, et al.
Published: (2025-07-01)

DETECTING PAINLESS MYOCARDIAL ISCHEMIA IN A PATIENT WITH RESTENOSIS AFTER PERCUTANEOUS CORONARY INTERVENTION
by: M. A. Elkanova, et al.
Published: (2016-07-01)

Risk Factors of Coronary In–Stent Restenosis in Drug-Eluting Stent: A Systematic Review and Meta-Analysis
by: Hotmauli Siahaan, et al.
Published: (2025-07-01)

Use of Clinical Parameters and Strain Echocardiography to Predict Stenosis Severity based on Gensini’s Score in Stable Coronary Artery Disease
by: Arif Sejati, et al.
Published: (2019-09-01)

Effects of probucol on restenosis after percutaneous coronary intervention: a systematic review and meta-analysis.
by: Jichen Liu, et al.
Published: (2015-01-01)

Role of early increase in vascular endothelial growth factor-A levels after coronary stenting in the development of drug-eluting in-stent restenosis
by: V. V. Tishko, et al.
Published: (2024-06-01)

Antioxidant system gene polymorphism and restenosis risk after coronary stenting
by: Yu. A. Shuvalova, et al.
Published: (2008-10-01)

Clinical condition and cardiovascular risk factors displaying neoatherosclerosis in stented coronary arteries with developing restenosis
by: V. P. Mazaev, et al.
Published: (2016-10-01)

Acute Coronary Stent Infection With Pseudoaneurysm Formation and Stent Separation After Percutaneous Coronary Intervention
by: Malin Renee Flygel, MD, et al.
Published: (2025-07-01)

Management of in-stent restenosis after iliofemoral venous stenting
by: XU Huimin, GAO Hongxia
Published: (2024-11-01)

A Subtraction Coronary Computed Tomography Angiography Technique to Evaluate In-stent Restenosis
by: Yan ZHOU, et al.
Published: (2025-07-01)

Relationship between Symptoms of Depression and Anxiety with Major Adverse Cardiac Event in 7 days in Patients with Acute Coronary Syndrome in Cipto Mangunkusumo Hospital
by: Diah Pravita Sari, et al.
Published: (2018-12-01)

Serum Angptl2 and CyPA Levels in Acute Myocardial Infarction and In-Stent Restenosis After Percutaneous Coronary Intervention: A Single-Center Retrospective Case-Control Study
by: Zhou P, et al.
Published: (2025-04-01)

Safety and Efficacy of Different Stent Strategies in Percutaneous Coronary Intervention
by: Waqas Ullah, MD, RPVI, et al.
Published: (2025-03-01)

Effect of rapamycin-eluting stents on in-stent restenosis and early inflammatory response in coronary artery narrowing animal models
by: Jianbing Zhang, et al.
Published: (2025-01-01)

Paclitaxel eluting stents versus bare metal stents restenosis
by: Ronald Aroche Aportela, et al.
Published: (2021-12-01)

Outcome of Coronary Edge In-stent Restenosis Management by Restenting Versus Drug-Eluting Balloon
by: Yasser Gaber Metwally, et al.
Published: (2024-12-01)

Impact of Obstructive Sleep Apnea on In-Stent Restenosis in Coronary Heart Disease Patients after Elective Drug-Eluting Stenting
by: Wenjie Yang, et al.
Published: (2025-01-01)

Impact of Arterial Stiffness on In-Stent Restenosis in the Era of Drug-Eluting Stents
by: Yiquan Huang, et al.
Published: (2025-06-01)

Construction and Analysis of an LncRNA-miRNA-mRNA Network Based on Competitive Endogenous RNA Reveal miRNAs Potentially Involved in In-stent Restenosis after Percutaneous Coronary Intervention
by: Xiao Jin, et al.
Published: (2023-12-01)

Very late stent thrombosis of bare-metal coronary stent nine years after primary percutaneous coronary intervention
by: Đurić Predrag, et al.
Published: (2016-01-01)

Extended follow-up of the Essential Pro paclitaxel drug-eluting balloon for in-stent restenosis
by: Lucio Padilla, et al.
Published: (2025-05-01)

The predictive value of preprocedural laboratory data in patients with coronary artery restenosis in various types of stents
by: D. V. Shames, et al.
Published: (2019-04-01)

Stent-in-Stent Endovascular Correction in Right Internal Carotid Artery Restenosis: a Clinical Case
by: T. N. Khafizov, et al.
Published: (2021-04-01)